Over the course of the past months, Rich Tv Live has emerged as one of the most interesting YouTube channels for investors. The channel publishes new videos every day and one of the more important video series is the one on ‘secret penny stock.
In this series, the analyst picks a new penny stock that might be a bit under the radar among investors. In the latest video, Rich Tv Live picked pharmaceutical company Vivos Inc. (OTCQB: RDGL).
As everyone knows, penny stocks by definition trade below $5 a share, and hence, it is possible for investors to make a killing if the stock moves in the right direction. Although these stocks can be volatile, significant news can affect the stock price like is the case with any other category of stocks.
The stock has had an explosive past few weeks. Over a period of only two weeks, the Vivos stock soared from only 2 cents to 24 cents. However, that rally was only the start of the rally in Vivos. The company made a major announcement on Monday with regards to its product Radiogel and that resulted in another major spike in the stock.
The Vivos stock soared by as much as 136% on Monday after the announcement from the company. In such a situation, it is only natural for investors to perhaps take a closer look at the announcement and watch the price action in the stock this week.
On Monday, the company announced that it had made its submission for a Breakthrough Device Designation for its product Radiogel to the United States Food and Drug Administration. It is a significant development for the company since it is a well-known fact that if the product does get the designation then it will have priority over meetings with the FDA.
The company made this submission ahead of the pre-submission meeting that has already been planned with the FDA. However, VIVOS also added that the pre-submission meeting is going to be set up at some point ‘in the near future’. There are some very important developments that are going to come up over the coming weeks. Hence, it could be quite worthwhile for investors to keep their eyes peeled.
Featured image: Pixabay